Delivery Order SPE2DB22D3401-SPE2DB25FT6JM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Fycompa 2 mg tablets (30-count packaging) with a contract ceiling value of $1,637.80. This firm fixed-price delivery order, which carries an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award required no set-aside designation and will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.14 to AmerisourceBergen Drug Corp for Fycompa 10 mg tablets (30-count package) on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $1,837.44. This firm fixed-price delivery order, which is expected to be completed by February 14, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Fycompa (perampanel) is an oral anticonvulsant medication used...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fycompa (perampanel) 0.5 mg/ml oral suspension in a 340ml unit, with a ceiling value of $3,176.22. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. Performance will be completed by July 15, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fycompa is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 MG tablets (30-count supply) valued at $1,752.54 under a firm fixed price contract type. The delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for FYCOMPA 4 mg tablets (30-count package) with a ceiling value of $2,067.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 24, 2025, and the place of performance is located in Conshohocken, PA. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count units) valued at $2,094.26 on September 23, 2025, with completion scheduled for September 24, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed through AmerisourceBergen's existing contract vehicle with DLA. FYCOMPA (perampanel) is an oral antiepileptic medication used as adjunctive therapy for partial-onset seizures and primary...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6JMDelivery Order
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa (perampanel) 4 mg tablets in a 30-count quantity, with a contract value of $1,033.98 and a firm fixed price structure. The award, issued on September 22, 2025, with completion scheduled for September 23, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, enabling the delivery of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company maintains a substantial portfolio of competitively awarded federal contracts with DLA and other government healthcare entities, including the Defense Health Agency and U.S. Coast Guard. Fycompa, an antiepileptic medication, falls within the company's demonstrated capability to supply specialty medications and branded pharmaceuticals to support military medical supply chain requirements. As a non-set-aside award, this delivery order reflects the contractor's ability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/22/25 |